Cost‐effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial

AbstractWomen with active rheumatoid arthritis who were judged to be in need of hospitalization were assigned at random to receive inpatient therapy (n = 35) or intensive outpatient therapy (n = 36). All relevant costs of treatment were measured. At 19 weeks, clinical outcomes, as summarized in a pooled index, were significantly better in the inpatient group (pooled index units: inpatient 0.72, outpatient 0.25; F[1,69] = 10.9, P = 0.002). Inpatient therapy produced a sustained threefold increase in efficacy, at a 2.5‐fold increase in cost to society.

Cost‐effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial Journal Articles